Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this study, the aim is to identify the modifications responsible for aseptic osteonecrosis of the femoral head and its structural evolution by the association of the micro scanner analysis and Raman spectrometry performed on the femoral heads removed during hip replacements. The study of femoral heads will allow the analysis of bone tissue at two different scales, both correlated with the biomechanical properties of the bone. Also, the association with preliminary MRI analysis will provide pathogenic explanations correlated to these modifications.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Osteonecrosis group | Experimental | Patients with an aseptic osteonecrosis of the femoral head |
|
| Control group | Other | Patients with coxarthrosis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| femoral head removal | Procedure |
|
| Measure | Description | Time Frame |
|---|---|---|
| Osseous modifications responsible of osteonecrosis | through the study completion, an average of 18 months |
| Measure | Description | Time Frame |
|---|---|---|
| Total cross-sectional area | by using a contrast-enhanced nano-CT for the subchondral plate in necrotic zone, juxta-necrotic zone, remotely of the necrotic zone and cortical of the femoral collar | through the study completion, an average of 27 months |
| cortical bone area |
Not provided
Inclusion Criteria for experimental group:
Inclusion Criteria for control group:
Exclusion Criteria for the 2 groups:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tristan Pascart, MD | Hospital Group of the Catholic Institute of Lille | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Salengro CHU Lille | Lille | 59037 | France | |||
| Hospital Group of the Catholic Institute of Lille |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32871293 | Result | Cultot A, Norberciak L, Coursier R, Putman S, Cortet B, Paccou J, Pascart T, Budzik JF. BONE PERFUSION AND ADIPOSITY BEYOND THE NECROTIC ZONE IN FEMORAL HEAD OSTEONECROSIS: A QUANTITATIVE MRI STUDY. Eur J Radiol. 2020 Oct;131:109206. doi: 10.1016/j.ejrad.2020.109206. Epub 2020 Aug 5. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005271 | Femur Head Necrosis |
| ID | Term |
|---|---|
| D010020 | Osteonecrosis |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D009336 | Necrosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
by using a contrast-enhanced nano-CT for the subchondral plate in necrotic zone, juxta-necrotic zone, remotely of the necrotic zone and cortical of the femoral collar |
| through the study completion, an average of 27 months |
| cortical area fraction | by using a contrast-enhanced nano-CT for the subchondral plate in necrotic zone, juxta-necrotic zone, remotely of the necrotic zone and cortical of the femoral collar | through the study completion, an average of 27 months |
| cortical thickness | by using a contrast-enhanced nano-CT for the subchondral plate in necrotic zone, juxta-necrotic zone, remotely of the necrotic zone and cortical of the femoral collar | through the study completion, an average of 27 months |
| bone volume fraction | by using a contrast-enhanced nano-CT for the subchondral trabecular bone | through the study completion, an average of 27 months |
| trabecular number | by using a contrast-enhanced nano-CT for the subchondral trabecular bone | through the study completion, an average of 27 months |
| trabecular separation | by using a nano-CT for the subchondral trabecular bone | through the study completion, an average of 27 months |
| trabecular thickness | by using a contrast-enhanced nano-CT for the subchondral trabecular bone | through the study completion, an average of 27 months |
| Physico-chemical composition of the trabecular subchondral bone | mineralisation, carbonation, crystallinity, secondary structure of collagen, maturity of collagen, relative content of proteoglycans. These measures will be done for the trabecular subchondral bone in necrotic zone, juxta-necrotic zone, remotely of the necrotic zone and in the cortical of the femoral collar | through the study completion, an average of 27 months |
| Existence and extent of edema | this measure will be done on the T2-weighted sequences with fat suppression | through the study completion, an average of 27 months |
| Perfusion MRI sequence | morphological aspect of the enhancement curve, semi-quantitative parameters (slope, area under the curve, time to peak) and pharmacokinetic parameters | through the study completion, an average of 27 months |
| Medullary fat fraction in T1-weighted DIXON method | border of osteosclerosis, identification of a necrotic zone, extent of this zone | through the study completion, an average of 27 months |
| Evaluation of osteocyte and adipocyte viability in hematoxylin-eosin-saffron (HES) staining | through the study completion, an average of 27 months |
| Number and ramifications of sub-chondral microvessels by immuno-labeling with CD21 | through the study completion, an average of 27 months |
| Evaluation of the number of osteoclasts by TRAP (tartrate acid Phosphatase) staining | through the study completion, an average of 27 months |
| Mankin score for cartilage degradation by Safranin O staining | through the study completion, an average of 27 months |
| Lomme |
| 59462 |
| France |
| D010335 |
| Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |